AstraZeneca Pharma India Ltd Balance Sheet Annual

BSE: - | NSE: - | ISIN: - | Sector: -

8,272.00 -15.30 (-0.18%)Updated : 16 Jan 2026

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Liabilities Shareholders' Equity	1,518.12	1,078.03	984.87	856.56
Accumulated Depreciation Total	-151.79	-120.32	-110.26	-94.34
Cash Equivalents	509.33	486.70	497.84	439.60
Other Liabilities Total	15.32	6.21	8.56	7.50
Accrued Expenses	101.96	55.23	51.98	66.82
Common Stock Total	5.00	5.00	5.00	5.00
Other Current Assets Total	2.00	2.11	0.20	0.04
Prepaid Expenses	14.21	10.96	11.77	10.82
Total Assets	1,518.12	1,078.03	984.87	856.56
Current Portof LT Debt/ Capital Leases	6.28	1.81	3.52	3.61
Cash	26.81	18.87	2.50	8.82
Total Equity	770.35	711.92	588.69	511.39
Long Term Investments	3.40	-	3.10	2.93
Retained Earnings( Accumulated Deficit)	758.20	703.63	581.12	504.44
Total Common Shares Outstanding	2.50	2.50	2.50	2.50
Property/ Plant/ Equipment Total- Gross	215.37	185.16	180.45	171.03
Tangible Book Valueper Share Common Eq	307.88	283.92	235.48	204.56
Total Liabilities	747.77	366.11	396.18	345.17
Total Debt	35.73	4.59	7.21	8.63
Cashand Short Term Investments	536.14	505.57	500.34	448.51
Total Receivables Net	239.83	185.40	132.50	104.98
Notes Payable/ Short Term Debt	0.00	0.00	0.00	0.00
Accounts Receivable- Trade Net	186.87	155.40	109.31	87.71
Property/ Plant/ Equipment Total- Net	63.58	64.84	70.19	76.69
Total Current Liabilities	703.00	357.12	383.93	332.65
Total Inventory	550.17	228.67	190.66	141.32
ESOP Debt Guarantee	7.15	3.29	2.57	1.95
Accounts Payable	456.30	196.51	227.88	188.06
Other Currentliabilities Total	138.46	103.57	100.55	74.16
Total Long Term Debt	29.45	2.78	3.69	5.02
Intangibles Net	0.66	2.11	-	-
Other Long Term Assets Total	46.19	23.72	20.67	16.30
Note Receivable- Long Term	61.94	54.65	55.44	54.97
period Length	0.00	0.00	0.00	0.00
Total Current Assets	1,342.35	932.71	835.47	705.67
Capital Lease Obligations	29.45	2.78	3.69	5.02
Short Term Investments	-	-	-	0.09